Clinilabs invites you to their event
About this event
This session will focus on the management and operation of a phase 1 unit, including discussion of SOPs, staff structure, facilities, instrumentation, safety equipment, pharmacy, and clinical laboratory. We also will cover important topics related to minor deviations, major deviations, and protocol violations.
Hosted by
Gary Zammit is a neuroscientist and sleep specialist who founded Clinilabs Drug Development Corporation in 2001. He is widely recognized as a key opinion leader in the field of sleep medicine, and has been involved in the development of new drugs to treat sleep disorders such as narcolepsy, insomnia, excessive sleepiness, and circadian rhythm disorders.
We are a global, full-service contract research organization (CRO), the only one focused exclusively on central nervous system (CNS) drug development. We are dedicated to bringing new therapies to patients living with mental health, neurological and substance abuse disorders.
